Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% Solution/ Drops
Product Images NDC 62332-545

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% (NDC 62332-545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Timolol-gfs-bottle-025 (Timolol Gfs Bottle 025)

Timolol-gfs-bottle-025 (Timolol Gfs Bottle 025)
Timolol Maleate is an ophthalmic gel solution utilized in the treatment of glaucoma. It contains 3.4mg/mL timolol maleate that is equivalent to 25mg of timolol. The usual adult dosage is applying one drop in the eye once every day. The package insert should be seen in case of confusion with the instructions. The product must be stored between 15° to 25°C (59° to 77°F) and protected from light. Freezing should be avoided as well. The product has an NDC number of 62332-545-05, and its lot number is PSLAB-020789-01, with expiry date 08/2021. M.L.No. 103/AP/RR/97/F/R is presented, and it is a product of Alembic.*
FDA Label Image

Timolol-gfs-bottle-05 (Timolol Gfs Bottle 05)

Timolol-gfs-bottle-05 (Timolol Gfs Bottle 05)
This is a description of a sterile medication called Timolol Maleate Ophthalmic Gel Forming Solution, used to treat eye problems. The medication has a dosage of 1 drop in the eye once a day for adults. The package insert provides more information about usage. The medication should be stored at 15° to 25°C (59° to 77°F) and should be protected from light. The NDC number is 62332-546-05, and the label includes a lot number and expiration date.*
FDA Label Image

Timolol-gfs-carton-025 (Timolol Gfs Carton 025)

Timolol-gfs-carton-025 (Timolol Gfs Carton 025)
This text is a description of an ophthalmic gel-forming solution that contains Timolol Maleate, a medication used to treat high pressure in the eyes (ocular hypertension) or open-angle glaucoma. The solution comes in a 5mL container and is sterile for topical application directly into the eyes. The inactive ingredients include tromethamine, mannitol, and water for injection, among others. A pharmacist should dispense the solution, and it must be kept in its original container free from contamination. The accompanying package insert should be reviewed to follow the doctor's prescriptions and precautions. The solution should be stored at between 15℃ and 25℃ and protected from light. The product is manufactured by Gland Pharma Limited, Hyderabad – 500 043, India, and distributed by Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA.*
FDA Label Image

Timolol-gfs-carton-05 (Timolol Gfs Carton 05)

Timolol-gfs-carton-05 (Timolol Gfs Carton 05)
Timolol Maleate Ophthalmic Gel Forming Solution is a prescription medication that is sterile when manufactured, and for topical application in the eye. It contains 6.8 mg timolol maleate in 1 mL and is equivalent to 5 mg/mL timolol. This product should be stored between 15° to 25°C, protected from light, and must be dispensed in the original unopened container. One drop of the solution must be applied in the eye once daily, following the doctor's instructions. Inactive ingredients include gelan gum, tromethamine, mannitol, and water for injection, and it contains benzododecinium bromide 0.012% as a preservative. It is manufactured by Gland Pharma Limited in Hyderabad, India, and is distributed in the United States by Alembic Pharmaceuticals, Inc.*
FDA Label Image

Timolol-gfs-figure-1 (Timolol Gfs Figure 1)

Timolol-gfs-figure-1 (Timolol Gfs Figure 1)
This appears to be a graph or chart related to a U.S. study of the drug timolol maleate in a gel-forming solution at a concentration of 0.5%, as well as a drug called Timoptic at a concentration of 0.5%. The graph displays the drug's effectiveness over a 24-hour period, with measurements taken at various times throughout the day over the course of several weeks.*
FDA Label Image

Timolo-gfs-figure-2 (Timolol Gfs Figure 2)

Timolo-gfs-figure-2 (Timolol Gfs Figure 2)
This is a study evaluating the effectiveness of Timolol maleate ophthalmic gel forming solution 0.5% once a day versus TIMOPTIC 0.5% twice a day for reducing intraocular pressure. The study includes 226 participants for the former and 116 for the latter, and measures were taken at specified intervals over the course of several weeks. The table shows changes in pressure over time.*
FDA Label Image

Timolol-gfs-ifu-fa (Timolol Gfs Ifu Fa)

FDA Label Image

Timolol-gfs-ifu-fb (Timolol Gfs Ifu Fb)

FDA Label Image

Timolol-gfs-ifu-fc (Timolol Gfs Ifu Fc)

FDA Label Image

Timolol-gfs-structure (Timolol Gfs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.